will take place on Thursday, June 8, 2017 at 2 pm in CBBM, 3.OG, Pharma Meeting Room.Host: Prof. Markus SchwaningerInstitute of Experimental and Clinical Pharmacology and ToxicologyUniversity of LübeckBiosketch
Ludovic Collin obtained his PhD in Life Sciences, Molecular and Cellular Biology at the University of Strasbourg in 2003. In 2004, he moved to the laboratory of Prof. Alan Hall (MRC LMCB, London) as an EMBO post-doctoral fellow where he worked on microtubule dynamics in migrating neurons. During that time he strengthened his expertise in high resolution confocal imaging for which he received 2 Awards of Excellence from the Wellcome Trust in 2006. Then, Ludovic joined EISAI Co., Ltd as a Research Scientist in the Neuroscience Product Creation Unit (London, UK). His drug discovery activities focused on Alzheimer’s disease and clearance of aggregate prone proteins. In 2011, Ludovic joined the NORD-DTA of Hoffmann La Roche (Basel, Switzerland) as a laboratory head and project leader in preclinical research. Besides leading drug discovery projects, his main research interests are the Blood-Brain Barrier and the mechanisms regulating transcytosis in health and disease.
